Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 1/2a Findings Lend Support for BB-301 in Oculopharyngeal Muscular Dystrophy
2
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1
3
Newer Oral Levodopa Formulations in Parkinson’s Disease
4
Evaluating Durable Dysphagia Outcomes in OPMD: Insights From Early BB-301 Clinical Data
5